Connect with us

Tranxene (clorazepate)


Clorazepate (or TRANXENE®) is mainly prescribed to treat epilepsy, anxiety disorders, sleep disorders, and alcohol withdrawal syndrome.

FDA Approval: 1987

Dosage Forms: 3.75 mg, 5 mg, 7.5 mg, 10 mg, 15 mg, 20 mg, 50 mg

Biological Half-life: 48 hours

Side Effects: Dizziness, sleepiness, ataxia, confusion, anterograde amnesia, poor concentration, lack of coordination

Routes of Administration: Oral

Pregnancy Category: D (US)

  www.fda.gov

Like Us

Advertisement
Advertisement